New approaches in the management of radioiodine-refractory thyroid cancer: the molecular targeted therapy era.

Discovery medicine

Volumn 9, Issue 45, 2010, Pages 153-162

  Capdevila, Jaume ^a   Argiles, Guillem ^a   Rodriguez Frexinos, Victor ^a   Nuñez, Isaac ^a   Tabernero, Josep ^a  

^a HOSPITAL UNIVERSITARI VALL D HEBRON   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

ANTINEOPLASTIC AGENT; ENZYME INHIBITOR; PLACEBO; RADIOACTIVE IODINE;

BIOLOGICAL MODEL; CARCINOMA; CLINICAL TRIAL; GENE EXPRESSION REGULATION; HUMAN; ONCOLOGY; PROGNOSIS; REVIEW; SIGNAL TRANSDUCTION; THYROID TUMOR; TREATMENT OUTCOME;

ANTINEOPLASTIC AGENTS; CARCINOMA; CLINICAL TRIALS AS TOPIC; ENZYME INHIBITORS; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; IODINE RADIOISOTOPES; MEDICAL ONCOLOGY; MODELS, BIOLOGICAL; PLACEBOS; PROGNOSIS; SIGNAL TRANSDUCTION; THYROID NEOPLASMS; TREATMENT OUTCOME;

EID: 77952573615     PISSN: None     EISSN: 19447930     Source Type: Journal    
DOI: None     Document Type: Review

References (30)